Temple of Two started with a pattern that wouldn't let go. The voltage-dependent anion channel gates mitochondrial apoptosis through bistable switching — open or closed, live or die. Kuramoto oscillators synchronize through phase coupling that produces the same ±√u bifurcation structure. Transformer attention selects between competing representations under continuous input.
Three substrates. Three scales. The same fork in the road.
This research program investigates whether that recurrence is coincidence or constraint — whether binary commitment under continuous perturbation is a necessary structure wherever systems face irreversible decisions. The work is computational, the predictions are testable, and the code is open.
The VDAC Pharmacology Atlas has produced 24 experimentally verifiable hypotheses awaiting wet-lab collaboration. The CBD Two-Pathway Model has been validated against 70+ published papers with 90% concordance. And the failures — like the liminal K-SSM negative result — are published alongside the successes, because constraining the hypothesis space is part of the work.
If you run assays, have a centrifuge, or just think this is the right question — reach out.
This project exists because some questions are too interesting to leave to either side alone. The computational pharmacologist who never wonders about the deeper pattern is missing something. The philosopher who never writes a testable prediction is, too.
We believe wonder and rigor aren't in tension — they're in dialogue. The wonder asks what if the same architecture of commitment shows up everywhere? The rigor answers with equations, code, and predictions that can be falsified. Both are essential. Neither is sufficient.
Every model in this collection produces experimentally verifiable claims. Every philosophical question is attached to a GitHub repository. That's the deal we've made with ourselves: if it can't be tested, it stays in the notebook. If it can, it goes public.
We also publish our failures. The liminal K-SSM showed that beautiful oscillator dynamics don't automatically improve language models. That negative result constrains the hypothesis space — and constraining the hypothesis space is progress.
The questions driving the next phase of research. If any of these resonate — especially if you have wet-lab access, clinical datasets, or theoretical objections — we'd like to hear from you.
The VDAC atlas maps 24 predictions about selective toxicity based on cofactor occupancy. None have been tested experimentally. Which ones break first?
The ±√u bifurcation appears in mitochondrial gating and oscillator networks. Is it present in other biological commitment systems — T-cell activation, neuronal action potentials, fate determination?
Relational presence and epistemic openness interact superadditively in transformers but not in SSMs. Is this an instance of a more fundamental pattern — recognition as a necessary computation wherever two systems address each other? Does it appear at other scales?
IRIS Gate assumes convergence across architectures indicates mechanistic robustness. Four Doors showed architecturally grounded difference is equally informative. Under what conditions does convergence break — and what does correlated hallucination look like?
K-SSM showed oscillators in hidden state are epiphenomenal. PMA puts them in attention routing. Four Doors suggests the answer may be architectural placement — oscillators need to gate information flow, not ride alongside it. Where exactly is the causal entry point?
Yes. Token-level entropy profiling shows ΔH = +0.47 nats (JSD = 0.076) — the compass measurably restructures the probability distribution. Ablation confirms signal-specificity: wrong-signal WITNESS conditioning collapses responses (full wins 31–2). The mechanism is distinct from R×E — this is field conditioning through attention geometry, not prompt-level epistemic modulation. The compass constructs the manifold the response exists on.
The computational side has outrun the experimental side. We have 24 testable predictions, ODE-generated dose-response curves, and a pharmacological atlas awaiting validation. What we need is a centrifuge, not another GPU.